EN DE
Watch Owlet Inc for free: once a week we email you where price and fair value stand.
Data-driven stock valuation

Owlet Inc (OWLT) fair value: what the stock is really worth

As of Nov 20, 2026: fair value (intrinsic value) of Owlet Inc stock $2.73, price $2.93, that is 6.8% below the price, quality 39 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently applies, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US · ISIN US69120X1072

OI Owlet Inc logo Thin data Nov 15, 2026

Owlet Inc

OWLT · US

The stock is already about fairly priced, weak company and falling price: meets none of the 3 rules.

Follow free in the weekly email
Low debt 
Revenue last quarter +30% vs. a year ago. 
Fair value $2.73 · Fairly valued 
Expensive Growth (revenue 5y +7.0 %/yr in USD) 
Quality 39/100 
Falling price (downtrend) 
Loss-making · -8.4% net margin (TTM) 
Negative free cash flow 
Trails peers (3/9) 
Narrow moat 10/100 · thin data
Thin data 
Estimate
Watch Owlet Inc for free: once a week we email you where price and fair value stand. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$135.10 $2.80 Fair Value $2.73 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.

How to read this chart

60‑month range $2.80 – $135.10 · fair‑value band $2.05 – $3.41 · the $2.93 price screens above the $2.73 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.

Follow Owlet in your weekly email

Every Wednesday you see whether Owlet is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Owlet, Inc. provides digital parenting solutions in the United States, the United Kingdom, and internationally. The company offers a digital parenting platform that provides real-time data and insights to parents.

Show moreShow less

It also provides sock monitors, including Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology that tracks vital signs, such as pulse rate, activity, oxygen level, and sleep patterns; BabySat, which is intended for infants with conditions, including respiratory syncytial virus, pneumonia, bronchitis, croup, and other diagnoses; and Dream Sight, an audio and video monitor that enables parents to monitor their child.

In addition, the company offers Dream Duo, which integrates Dream Sock and Dream Sight to create a connected health and safety system; Owlet360, a subscription service that provides personalized understanding of the babies' development, health, and sleep trends; and accessories, such as fabric accessory socks and the Owlet Sock Travel Case.

The company was founded in 2012 and is headquartered in Lehi, Utah.

Stock analysis

Owlet Inc (OWLT) currently trades at $2.93, while our estimate is $2.73, so the stock looks roughly fairly valued today (gap 7.3%).

Show more

Valuation

None of our valuation models currently applies to this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: $2.05 (bear) to $3.41 (bull), the price of $2.93 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 39/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Owlet Inc reported revenue of $106M in FY2025 versus $75.8M in FY2021, a compound +8.7%/yr. Reported net income was −$39.7M in FY2025.

Key figures

Market cap $85.6M Micro · P/S ratio 0.88 · EPS (TTM) $-0.54 · Net margin −8.4% · Return on equity −526% · Return on assets (EBIT) −60.2% (5-year average) · Operating margin −7.1% · Revenue (TTM) $114M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (low confidence).

What moves the price

The share trades about 82% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 7% fair-value upside, at −7%, OWLT screens richer than that median.

Fair Value

Bear $2.05 Fair Value $2.73 Bull $3.41
Price $2.93 · Downside -6.8%
Estimate. None of our valuation models currently applies to this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 39/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 39
How much profit the company makes from its sales and capital
Quality Growth 31
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 60
Debt, balance sheet and risk of trouble
Investment 66
Does it invest with discipline instead of growing at any price?
Low Volatility 0
How calm the share price moves, does not count
Price momentum 0
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 50
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, no officer or director bought or sold shares on the open market.

  • SaleAmanda CrawfordChief Financial Officer2× since Jan 20, 2026: 7,075 shares, avg. $11.55$81,697Feb 27, 2026
  • SaleJonathan HarrisFormer President & CEO2× since Jan 20, 2026: 18,527 shares, avg. $11.57$214,281Feb 26, 2026

Plus 7 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 20, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 28/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+35.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.0%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.4%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−9.3% (2020) → −7.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch OWLT, get fair value alerts →

Compare Owlet Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 399 stocks

Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 39 · Below median
Fair Value upside −6.8% · Above median
Profitability
Return on assets −46.4% · Bottom 25%
Net margin (12 months) −8.4% · Below median
Operating margin (12 months) −7.1% · Below median
Growth and dividend
Revenue growth (quarter YoY) 29.9% · Top 25%
Balance sheet
Debt / equity 0.07× · Above median

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/B 2.42× · Pricier than median
P/S (12 months) 0.75× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)24 · sector 19
FUTURE (revenue growth)100 · sector 41
PAST (return on equity)0 · sector 2
HEALTH (low debt)97 · sector 97
DIVIDEND (yield)0 · sector 35

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Stryker Corporation SYK $310.00 $341.00 +10% vs OWLT
Boston Scientific Corporation BSX $41.98 $46.18 +10% vs OWLT
DexCom, Inc DXCM $79.32 $87.25 +10% vs OWLT
STERIS plc STE $255.76 $281.34 +10% vs OWLT
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥183.81 ¥197.34 +7% vs OWLT
GE HealthCare Technologies Inc GEHC $80.64 $69.92 −13% vs OWLT
Edwards Lifesciences Corporation EW $101.85 $81.94 −20% vs OWLT
Medtronic plc MDT $99.94 $74.89 −25% vs OWLT
Abbott Laboratories, ABT $103.00 $75.28 −27% vs OWLT
Koninklijke Philips N.V PHIA €26.39 €15.23 −42% vs OWLT

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Owlet Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Owlet Inc Fair Value". https://www.fairvalue-calculator.com/stock/OWLT

Frequently asked questions

Is Owlet Inc (OWLT) overvalued or undervalued?
As of Nov 15, 2026, our estimate of fair value is $2.73 versus a price of $2.93, about 7% lower (fairly valued).
What is the fair value of OWLT?
Our estimate for Owlet Inc is $2.73 (as of Nov 15, 2026), built from audited fundamentals. The current price: $2.93.
What is the quality score of OWLT?
Owlet Inc has a Quality Score of 39/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Owlet Inc (OWLT)?
We do not set a price target; the yardstick is our estimate of $2.73 (as of Nov 15, 2026). Cautious scenario $2.05, optimistic scenario $3.41. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently applies, not an analyst target.
What is the Owlet Inc stock forecast for 2026?
Our estimate puts fair value at $2.73, about 7% lower versus a price of $2.93 (fairly valued). Cautious scenario $2.05, optimistic scenario $3.41. The calculation is refreshed regularly with new filings.
What is the revenue of Owlet Inc (OWLT)?
Owlet Inc reported trailing-twelve-month revenue of about $114M (latest available figure, as of Nov 15, 2026).
What is the intrinsic value of Owlet Inc (OWLT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Owlet Inc it is $2.73 per share (as of Nov 15, 2026), against a price of $2.93.
Is Owlet Inc stock overvalued or undervalued in 2026?
As of Nov 15, 2026, OWLT trades above its calculated fair value: price $2.93, fair value $2.73, a gap of about −7% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of OWLT?
No. The price is what the market pays today ($2.93); the fair value is what the company's own numbers justify ($2.73). For Owlet Inc the two are $0.199 per share apart. That gap is exactly why we show both numbers side by side.
How much is Owlet Inc worth?
The market values Owlet Inc at about $85.6M (market capitalisation, as of Nov 15, 2026). Per share that is $2.93; our models calculate a fair value of $2.73 per share.
What do the bullish and bearish scenarios say about OWLT?
Our models span a range for Owlet Inc: cautious scenario $2.05, base $2.73, optimistic $3.41 per share (as of Nov 15, 2026, price $2.93). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Owlet Inc (OWLT)?
Balance-sheet figures for Owlet Inc (as of Nov 15, 2026): debt of 0.07 per unit of equity. They feed the Quality Score of 39/100, which measures business quality independently of the share price.
How far is OWLT from its 52-week high?
Owlet Inc trades at $2.93, about 82% below its 52-week high of $16.52 and at the low of $2.93 (as of Nov 20, 2026). Distance from the high says nothing about value: that is what the fair value of $2.73 is for.
Which stocks are comparable to Owlet Inc?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Owlet Inc stock attractive at the current price?
The data as of Nov 15, 2026: price $2.93, calculated fair value $2.73 (−7%), Quality Score 39/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 10.1% above its aggregate fair value. Owlet Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Owlet Inc (OWLT)?
The closing price on Nov 20, 2026 was $2.93. Our estimate is $2.73, about 7% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Owlet Inc right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Owlet Inc

How large is the market capitalisation of Owlet Inc (OWLT)?
The market capitalisation of Owlet Inc is $85.6M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Owlet Inc (OWLT)?
The price-to-sales ratio of Owlet Inc is 0.88 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Owlet Inc (OWLT)?
Earnings per share at Owlet Inc are $-0.54. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Owlet Inc (OWLT)?
The net margin of Owlet Inc is −8.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Owlet Inc (OWLT)?
The return on equity (ROE) of Owlet Inc is −526% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Owlet Inc (OWLT)?
On an EBIT basis the return on assets of Owlet Inc is −60.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Owlet Inc (OWLT)?
The operating margin of Owlet Inc is −7.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Owlet Inc (OWLT)?
Revenue at Owlet Inc is growing 29.9% in the last quarter versus the same quarter a year earlier (3y avg +15.2%). How much revenue grew in the last quarter versus the same quarter a year earlier (YoY). The 3-year average next to it puts the single quarter in context.
How much free cash flow does Owlet Inc (OWLT) generate?
The free cash flow of Owlet Inc is −$11.1M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Owlet Inc (OWLT) hold?
Owlet Inc holds more cash than debt, $22.5M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Owlet Inc in the live analysis

One click puts Owlet Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.